Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Series B Preferred Stock
Common Stock
Series B Preferred Stock
Additional Paid-In Capital
Series B Preferred Stock
Series C Preferred Stock
Common Stock
Series C Preferred Stock
Additional Paid-In Capital
Series C Preferred Stock
Common Stock
Previously Reported
Common Stock
Additional Paid-In Capital
Previously Reported
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Previously Reported
Accumulated Other Comprehensive Income
Accumulated Deficit
Previously Reported
Accumulated Deficit
Previously Reported
Total
Balance at Dec. 31, 2017     $ 6         $ 11,505   $ 89,750,749   $ 127,473   $ (91,816,655)   $ (1,926,922)
Balance (in shares) at Dec. 31, 2017     600         1,150,484                
Cumulative Effect of Change in Accounting Principle (Note 2)                           9,477,880   9,477,880
Stock-Based Compensation                   875,287           875,287
Stock Issuance Costs     $ (1,141,238)                         (1,141,238)
Issuance of Stock in Offering, Net of Offering Costs           $ 65   $ 9,820   10,098,877           10,108,762
Issuance of Stock in Offering, Net of Offering Costs (in shares)           6,536   982,000                
Conversion of Stock into Common Stock $ 267 $ (261) $ (6) $ 5,092 $ (5,068) $ (24)                    
Conversion of Stock into Common Stock(in shares) (26,667)   (600) (509,250)   (2,444)                    
Issuance of Shares of Common Stock from Warrant Exercises               $ 2,512   1,203,313           1,205,825
Issuance of Shares of Common Stock from Warrant Exercises (in shares)               251,208                
Cancellation of Restricted Stock (in shares)               (17)                
Cancellation and Correction of Restricted Stock Par Value               $ 1,190   (1,190)            
Cancellation and Correction of Restricted Stock Par Value (in shares)               (119,000)                
Foreign Currency Translation Adjustment                       (6,858)       (6,858)
Net Loss                           (10,811,423)   (10,811,423)
Balance at Dec. 31, 2018     $ 6     $ 41 $ 11,505 $ 30,386 $ 89,750,749 101,921,707 $ 127,473 134,331 $ (82,338,775) (93,150,198) $ 7,550,958 8,936,267
Balance (in shares) at Dec. 31, 2018     600     4,092 1,150,484 3,038,592                
Stock-Based Compensation                   852,230           852,230
Stock Issuance Costs                               (97,082)
Issuance of Stock in Offering, Net of Offering Costs               $ 6,000   1,771,918           1,777,918
Issuance of Stock in Offering, Net of Offering Costs (in shares)               600,000                
Cancellation of Fractional Shares due to Reverse Stock Split (in shares)               23                
Settlement of Fractional Shares due to Reverse Stock Split               $ (9)   (2,605)           (2,614)
Settlement of Fractional Shares due to Reverse Stock Split (in shares)               907                
Issuance of Shares of Common Stock from Warrant Exercises               $ 4,480   2,145,736           2,150,216
Issuance of Shares of Common Stock from Warrant Exercises (in shares)               447,961                
Cancellation of Restricted Stock               $ (79)   79            
Cancellation of Restricted Stock (in shares)               (7,868)                
Foreign Currency Translation Adjustment                       (5,134)       (5,134)
Net Loss                           (7,096,696)   (7,096,696)
Balance at Dec. 31, 2019           $ 41   $ 40,778   $ 106,689,065   $ 139,465   $ (100,246,894)   $ 6,622,455
Balance (in shares) at Dec. 31, 2019           4,092   4,077,755